Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRIN LAAO
NCT03821883Unknown
- Sponsor
- Xinhua Hospital
- Start
- Jun 2020
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of aspirin in Atrial fibrillation (AFib) (2 arms), sponsored by Xinhua Hospital. Primary endpoints: Number of Participants with stroke at 24 months, Number of participants with systemic embolism at 24 months and 4 more. Status: unknown.
02
Drugs
aspirin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03821883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03821883.